09 October 2011, 4: 25 AM EDT by numerous Barak Harif and Zachary Tracer
October 9 (Bloomberg) — the only non-Israeli company on the stock benchmark TA-25 index of Tel Aviv, Perrigo co., defying the market slump this year, is the most since 2007 on speculation that the maker of generic drugs more expensive brands will benefit from rising as consumers switch.
Perrigo, Allegan, Michigan-based company that joined the B'nei Brak, Israel-based index after buying Agis Industries Ltd. has 54% in 2005, while the TA-25 in 2011 climbed down 22%. Perrigo decreased 0.5% at 9: 55 hours in Tel Aviv after sliding in New York on October 7, 2.1%. The U.S.-shares fell 1.9% last week, while the Index of the largest U.s.-Israel Bloomberg 25 New York-traded Israeli companies increased by 0.6%, under the direction of The TA-25 Click Software Technologies Ltd. fell 0.8%.Perrigo, the biggest U.S. maker of generic over-the-counter drugs, benefit from the increasing demand for cheaper medicines amid slow economic growth and an unemployment rate that's stuck on about 9 percent. The company sells its products to Wal-Mart Stores Inc., the world's largest retailer, and CVS Caremark Corp., which has more than 7,000 shops around the country, according to its website.Perrigo has attractive growth within the current uncertain economic climate, especially with their supply of private label OTC drugs, which are often sold as cheaper alternatives, "says Jonathan Kreizman, a Tel Aviv-based analyst at Clal Finance Brokerage Ltd. The TA-25 Index, which is a bear market would have fallen 26 percent in August, as would have excluded from the meter, Perrigo according to data compiled by Bloomberg. TargetClal $ 100 raised finance its estimate of the stock price up to $ 100 on October 6. Perrigo said last week that the provisional approval of the u.s. Food and Drug Administration for medicine that treats problems with the scalp. Sales for the equivalent Stiefel Laboratories foam were about 40 million dollars in the 12 months ending September 2011, according to Wolters Kluwer. The company expects to increase revenues fiscal year 2012 up to 18 percent from this year, Chief Executive Officer Joseph Papa told investors on a Sept. 27 webcast. Sales rose 12 percent to $ 2.76 billion in the 12-month period ending on 25 June. "We are one of the few companies in the health care that a majority of their company not significantly from products that are covered by the third-party and Government, "said Papa DemandThe. higher company will benefit from the higher demand for store brands. Generics make up 32 percent of over-the-counter drugs sales in the US, of 10% in 1990 and 25 percent in 2009, according to Deutsche Bank AG. "Perrigo demonstrated very impressive growth, "said David Steinberg, a San Francisco-based analyst at Deutsche in an email report last week. The company "is the dominant player in the primary market with no major competitor," he said.The TA-25 Index is headed for the first annual decline in three years, with cheap Nochi Dankner holding Investment Corp., the billionaire with interests in telecommunications, manufacturing and retail trade, leading the decline.The benchmark entered bear-market territory after falling 20 percent from its record close on 21 April. The measure dropped 2.6% to 1, 049.92 last week.About 10 trillion of global stock markets was swept in the third quarter on the concerns that growth in the aftermath of the debt crisis in Europe will Abate. Federal Reserve Chairman Ben s. Bernanke said 4 October that the recovery will be "somewhat slower" in the coming quarters.Israel and the US 25 FallsThe Bloomberg Index Index of the largest New York-traded Israeli companies decreased 1.7 percent to 80.39 on October 7. that the shekel against the dollar was little changed on 3.7165 in New York. The currency has decreased by 3% in the past 12 months, the best performer under 10 emerging markets in Europe, the Middle East and Africa tracked by Bloomberg. Israel, whose population of 7.7 million is similar to Switzerland, has about 60 of companies traded on the Nasdaq Stock Market, the most of a country outside of North America after China. It is also home to the largest number of startup companies per capita in the world.Click Software, Petach Tikva, Israel-based company that counts EON AG and PG & E Corp. as customers for software that helps keep track of orders, fell 0.8% to $ 9.03 on 7 October. Those of the company profits for the week reduced to 16 percent, the most among the 25 largest New York-traded Israeli companies. Click Software strengthens its revenue forecast on October 3, after the announcement of that receiving an order from an electricity generator "multi-billion dollar".DropsTeva Teva Pharmaceutical Industries Ltd., the world's largest manufacturer of generic drugs, lost 1.4% to 137.9 sickles, or the equivalent of $ 37.1. The U.S.-shares fell 83 cents to $ 36.75 7 October after a unit of the company Petach Tikva-based and two other drug makers were ordered to pay at least $ 20.1 million for selling an anesthetic in a way that under the leadership of three patients to Hepatitis c. the New York-listed American depositary receipts traded with an 87% discount to the Tel Aviv-listed shares in New York last week, the second largest in the EZchip semiconductor index Bloomberg after Internet gold Golden lines Ltd. decreased.-1.3 percent to sickles, or the equivalent of $ 38.90 gelindo Bordin. The U.S.-shares fell 11 percent last week to $ 10.42, the biggest drop in the Bloomberg Israel-U.s. 25 Index. The Internet service provider (ISP), also located in Petah Tikva, said October 3 that the Chief Executive Officer Eli Holtzman withdrew.--With the help of Gwen Ackerman in Jerusalem. Editor: Brendan Walsh, Marie-France Han
Zachary Tracer in New York in ztracer1@bloomberg.net
Contact the reporters on this story: Many Barak Harif in New York in tbarak@bloomberg.net;
Contact the editor responsible for this story: David Papadopoulos to papadopoulos@bloomberg.net
0 comments
Post a Comment